Skip Navigation LinksHome > March 2014 - Volume 8 - Issue 1 > Editorial introductions
Text sizing:
A
A
A
Current Opinion in Supportive & Palliative Care:
doi: 10.1097/SPC.0000000000000042
Editorial introductions

Editorial introductions

Section Editor(s): Ahmedzai, Sam H.; Dickenson, Anthony H.; Chow, Edward; Beattie, James M.; Clemons, Mark

Free Access

Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editors and the Journal's Section Editors for this issue.

Back to Top | Article Outline

EDITORS

Sam H. Ahmedzai

Image Tools

Professor Sam H. Ahmedzai is Chair and Head of the Academic Unit of Supportive Care at the School of Medicine and Biomedical Science at the University of Sheffield, UK, where he has worked since 1994. He also works clinically as a Consultant Physician in palliative medicine in a multi-disciplinary symptom control and supportive care team in the Sheffield hospitals. He is Clinical Lead for the Sheffield Adult Cancer Survivorship and is a Council Member of the British Pain Society. He was formerly Medical Director of the Leicestershire Hospice.

Sam graduated from the Universities of St Andrews (Scotland) and Manchester. His medical training was in oncology and respiratory medicine. His research interests are in pain control, nutrition, respiratory palliation and holistic needs assessment. He initiated the Science Committee for the Association for Palliative Medicine (UK) and past chair of the European Organisation for Research and Treatment of Cancer's Groups on Quality of Life and on Pain and Symptom Control. The Sheffield Academic Unit has also led developments in consumer involvement in cancer research.

Back to Top | Article Outline
Anthony H. Dickenson

Image Tools

Anthony H. Dickenson, BSc, PhD, is Professor of Neuropharmacology in the Department of Pharmacology at University College, London, UK. He earned his PhD at the National Institute for Medical Research, London, has held posts in Paris, California and Sweden, and was appointed to the Department of Pharmacology at University College in 1983. His research interests are pharmacology of the brain, including the mechanisms of pain and how pain can be controlled in both normal and pathophysiological conditions, and how to translate basic science to the patient.

Professor Dickenson was a member of the Council of the International Association for the Study of Pain for 6 years and is an associate editor for the journal Pain. He has authored more than 280 refereed publications and has made many media appearances. Professor Dickenson has given plenary lectures at the World Congress on Pain, the American Pain Society, the European Pain Congress, the Canadian Pain Society, the Belgium Pain Society, the Scandinavian Pain Society, the British Pain Society, the Thailand Pain Society, the Irish Pain Society, the Australian Pain Society, the New Zealand Pain Society and many other international and national meetings. He has also spoken at the Royal Institution, to GPs and schools on pain.

Back to Top | Article Outline
Edward Chow

Image Tools

Dr Edward Chow is a Professor in the Department of Radiation Oncology at the University of Toronto, Canada and a Senior Scientist at Sunnybrook Research Institute, Toronto, Canada.

He is the Chair of the Rapid Response Radiotherapy Program and Bone Metastases Site Group at the Odette Cancer Centre, Sunnybrook Health Sciences Centre, where he is a staff Radiation Oncologist.

Back to Top | Article Outline

SECTION EDITORS

James M. Beattie

Image Tools

Dr James M. Beattie is Consultant Cardiologist at Birmingham Heartlands Hospital, UK part of the Heart of England NHS Foundation Trust which is a teaching hospital group linked to the University of Birmingham, UK. A graduate of the University of Glasgow, UK, he undertook initial cardiology training in the University Department at Glasgow Royal Infirmary, UK. He later pursued periods of research at the University of California, USA, at Davis and the University of Texas, USA, Southwestern Medical School. He returned to the UK as Lecturer in Cardiovascular Medicine at the University of Birmingham and was appointed to his current position in 1990. He is engaged in general adult cardiology practice and he is heart failure lead for the Trust. He holds fellowships of the Royal Colleges of Physicians of Glasgow, Edinburgh and London, UK, and is a fellow of the European Society of Cardiology.

He has had a long interest in palliative care for heart failure and for ten years was a National Clinical Lead with the NHS Heart Improvement Programme through which he contributed to the development of this aspect of heart failure care across England. He co-authored the position statement on heart failure palliative care from the European Society of Cardiology. He is a trustee of the National Council for Palliative Care and is Chair of their Heart Failure Group.

Back to Top | Article Outline
Mark Clemons

Image Tools

Dr Mark Clemons is a Clinical Investigator at the Ottawa Hospital Research Institute, Canada (Cancer Therapeutics Program), staff medical oncologist (Ottawa Hospital Cancer Centre, Canada) and Associate Professor (University of Ottawa, Canada). A proponent of high quality clinical trials research, he is involved in a large number of studies for patients with early stage, locally advanced and metastatic breast cancer. He is the recipient of multiple peer-reveiwed research grants and is widely published in the field of breast cancer management. His work on strategies to improve tissue acquisition during systemic therapy have also improved the assessment of both the efficacy of novel therapeutic agents but also innovative ways of administering established agents. His research vision is to focus specifically on moving biomarker studies into the clinic to provide individualized patient-tailored care.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login